2027 Best Value Clinical and Industrial Drug Development Master’s Degree Schools

[Clinical and Industrial Drug Development](/majors/health-care-professions/pharmacy-pharmaceutical-sciences/clinical-and-industrial-drug-development/) is a field worth comparing on the balance of cost and outcomes. A high-value program keeps cost low while graduates go on to earn well.
College Factual analyzed 8 schools to build this 2027 ranking of the best value clinical and industrial drug development schools.
What’s on this page:
2027 Best Value Clinical and Industrial Drug Development Schools in the United States
If you want to know which schools deliver the best value for the clinical and industrial drug development degrees they offer, see the list below.
Best Value Clinical and Industrial Drug Development Schools
For return on investment in clinical and industrial drug development, no school beat University Of California San Diego this year. University Of California San Diego is a very large public school located in the city of La Jolla. The average in-state cost of tuition and fees is $15,788, with out-of-state students paying around $47,676. Students borrow a median of $17,101 to complete the clinical and industrial drug development program here. Soon after graduation, clinical and industrial drug development degree recipients from University Of California San Diego generally make around $117,115. Weighed against typical debt, the earnings make a compelling case for value. Roughly 27% of applicants are accepted.
University Of Georgia came in at #2 on our 2027 list of the best value clinical and industrial drug development schools. Set in the city of Athens, University Of Georgia is a very large public institution. In-state tuition and fees average $11,450, with out-of-state students paying around $31,688. Typical student debt for clinical and industrial drug development graduates is $23,761. Clinical And Industrial Drug Development graduates of University Of Georgia earn a median of $117,869 early in their careers. Weighed against typical debt, the earnings make a compelling case for value. The acceptance rate is 38%.
University Of Washington Seattle Campus is a great value for students pursuing a degree in clinical and industrial drug development, landing the #3 spot this year. Located in the city of Seattle, University Of Washington Seattle Campus is a very large public university. The average in-state cost of tuition and fees is $12,973, compared with $43,209 for out-of-state students. Students borrow a median of $16,481 to complete the clinical and industrial drug development program here. Early-career clinical and industrial drug development graduates make about $119,313. Weighed against typical debt, the earnings make a compelling case for value. Roughly 39% of applicants are accepted.
Campbell University came in at #4 on our 2027 list of the best value clinical and industrial drug development schools. Set in the town of Buies Creek, Campbell University is a moderately-sized private not-for-profit institution. Students from in state pay about $41,600 in tuition and fees. Clinical And Industrial Drug Development graduates carry a median of $23,065 in student loans. Soon after graduation, clinical and industrial drug development degree recipients from Campbell University generally make around $77,008. That is a strong return on a $23,065 median debt. The acceptance rate is 87%.
A rank of #5 makes University Of Cincinnati Main Campus one of the best values for clinical and industrial drug development. University Of Cincinnati Main Campus is a very large public school located in the city of Cincinnati. In-state tuition and fees average $13,363, compared with $28,697 for out-of-state students. Students borrow a median of $23,530 to complete the clinical and industrial drug development program here. Early-career clinical and industrial drug development graduates make about $104,460. Set against $23,530 in median debt, that is a healthy payoff. University Of Cincinnati Main Campus admits about 85% of applicants.
Temple University ranked #6 on our 2027 list of the best value clinical and industrial drug development schools. Temple University is a very large public school located in the city of Philadelphia. Students from in state pay about $23,005 in tuition and fees, while out-of-state students pay about $38,805. Typical student debt for clinical and industrial drug development graduates is $26,259. Soon after graduation, clinical and industrial drug development degree recipients from Temple University generally make around $117,770. Weighed against typical debt, the earnings make a compelling case for value. The acceptance rate is 80%.
University Of Southern California earned the #7 position for value in clinical and industrial drug development this year. Set in the city of Los Angeles, University Of Southern California is a very large private not-for-profit institution. The average in-state cost of tuition and fees is $71,647. Typical student debt for clinical and industrial drug development graduates is $15,625. Early-career clinical and industrial drug development graduates make about $114,101. That is a strong return on a $15,625 median debt. Roughly 10% of applicants are accepted.
Massachusetts College Of Pharmacy And Health Sciences landed the #8 spot for clinical and industrial drug development value this year. Set in the city of Boston, Massachusetts College Of Pharmacy And Health Sciences is a moderately-sized private not-for-profit institution. Students from in state pay about $40,530 in tuition and fees. Students borrow a median of $27,000 to complete the clinical and industrial drug development program here. Soon after graduation, clinical and industrial drug development degree recipients from Massachusetts College Of Pharmacy And Health Sciences generally make around $88,535. Set against $27,000 in median debt, that is a healthy payoff. The acceptance rate is 85%.
Other Clinical and Industrial Drug Development Degree Levels
Looking for a different degree level? Compare best-value Clinical and Industrial Drug Development rankings across degree levels:
View All Clinical and Industrial Drug Development Rankings >
Notes and References
The ranking above is published by College Factual (MF_RANKING_2025), 2027 edition. Schools are scored on the balance of cost (tuition and student debt) against student outcomes (post-graduation earnings) — a measure of return on investment, drawn primarily from the U.S. Department of Education (IPEDS and College Scorecard).
Ranking method: College Major Best Value · 8 schools evaluated.
*Averages shown above reflect the top 8 ranked schools only.
- The Integrated Postsecondary Education Data System (IPEDS) from the National Center for Education Statistics (NCES), a branch of the U.S. Department of Education (DOE), serves as the core of our data about colleges.
- Some other college data, including much of the graduate earnings data, comes from the U.S. Department of Education’s (College Scorecard).
More about our data sources and methodologies.